Literature DB >> 7514139

Cloning and expression of a cDNA for the human prostacyclin receptor.

M Katsuyama1, Y Sugimoto, T Namba, A Irie, M Negishi, S Narumiya, A Ichikawa.   

Abstract

A functional cDNA for the human prostacyclin receptor was isolated from a cDNA library of CMK cells, a human megakaryocytic leukaemia cell line. The cDNA encodes a protein consisting of 386 amino acid residues with seven putative transmembrane domains and a deduced molecular weight of 40,956. [3H]Iloprost specifically bound to the membrane of CHO cells stably expressing the cDNA with a Kd of 3.3 nM. This binding was displaced by unlabelled prostanoids in the order of iloprost = cicaprost >> carbacyclin > prostaglandin E1 (PGE1) > STA2. PGE2, PGD2 and PGF 2 alpha did not inhibit it. Iloprost in a concentration-dependent manner increased the cAMP level and generated inositol trisphosphate in these cells, indicating that this human receptor can couple to multiple signal transduction pathways.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7514139     DOI: 10.1016/0014-5793(94)00355-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  Prostacyclin receptor-independent inhibition of phospholipase C activity by non-prostanoid prostacyclin mimetics.

Authors:  K B Chow; Y H Wong; H Wise
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

2.  Prostaglandin I2 Signaling and Inhibition of Group 2 Innate Lymphoid Cell Responses.

Authors:  Weisong Zhou; Shinji Toki; Jian Zhang; Kasia Goleniewksa; Dawn C Newcomb; Jacqueline Y Cephus; Daniel E Dulek; Melissa H Bloodworth; Matthew T Stier; Vasiliy Polosuhkin; Rama D Gangula; Simon A Mallal; David H Broide; R Stokes Peebles
Journal:  Am J Respir Crit Care Med       Date:  2016-01-01       Impact factor: 21.405

3.  Effect of a prostaglandin I(2) analog on the expression of thrombomodulin in liver and spleen endothelial cells after an extensive hepatectomy.

Authors:  Masanobu Usui; Hiroyuki Kato; Naohisa Kuriyama; Yoshinori Azumi; Masashi Kishiwada; Shugo Mizuno; Hiroyuki Sakurai; Masami Tabata; Tatsuya Hayashi; Koji Suzuki; Shuji Isaji
Journal:  Surg Today       Date:  2011-01-26       Impact factor: 2.549

4.  Activated endothelial cells elicit paracrine induction of epithelial chloride secretion. 6-Keto-PGF1alpha is an epithelial secretagogue.

Authors:  E D Blume; C T Taylor; P F Lennon; G L Stahl; S P Colgan
Journal:  J Clin Invest       Date:  1998-09-15       Impact factor: 14.808

5.  Hepatocyte growth factor as a key to modulate anti-ulcer action of prostaglandins in stomach.

Authors:  M Takahashi; S Ota; Y Hata; Y Mikami; N Azuma; T Nakamura; A Terano; M Omata
Journal:  J Clin Invest       Date:  1996-12-01       Impact factor: 14.808

6.  Assembling NMR structures for the intracellular loops of the human thromboxane A2 receptor: implication of the G protein-coupling pocket.

Authors:  Jiaxin Wu; Mary Feng; Ke-He Ruan
Journal:  Arch Biochem Biophys       Date:  2007-12-03       Impact factor: 4.013

7.  A simple, quick, and high-yield preparation of the human thromboxane A2 receptor in full size for structural studies.

Authors:  Ke-He Ruan; Vanessa Cervantes; Jiaxin Wu
Journal:  Biochemistry       Date:  2008-06-05       Impact factor: 3.162

Review 8.  Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biology.

Authors:  Matthew W Buczynski; Darren S Dumlao; Edward A Dennis
Journal:  J Lipid Res       Date:  2009-02-24       Impact factor: 5.922

9.  A strategy using NMR peptide structures of thromboxane A2 receptor as templates to construct ligand-recognition pocket of prostacyclin receptor.

Authors:  Cheng-Huai Ruan; Jaixin Wu; Ke-He Ruan
Journal:  BMC Biochem       Date:  2005-11-04       Impact factor: 4.059

10.  Putative role of prostaglandin receptor in intracerebral hemorrhage.

Authors:  Shekher Mohan; Abdullah S Ahmad; Alexander V Glushakov; Chase Chambers; Sylvain Doré
Journal:  Front Neurol       Date:  2012-10-22       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.